Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

918 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T₁ mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study.
Ng AC, Auger D, Delgado V, van Elderen SG, Bertini M, Siebelink HM, van der Geest RJ, Bonetti C, van der Velde ET, de Roos A, Smit JW, Leung DY, Bax JJ, Lamb HJ. Ng AC, et al. Among authors: de roos a. Circ Cardiovasc Imaging. 2012 Jan;5(1):51-9. doi: 10.1161/CIRCIMAGING.111.965608. Epub 2011 Dec 1. Circ Cardiovasc Imaging. 2012. PMID: 22135399
Six-months of recombinant human GH therapy in patients with ischemic cardiac failure.
van Thiel SW, Smit JW, de Roos A, Bax JJ, van der Wall EE, Biermasz NR, Viergever E, Vliegen HW, Romijn JA, Roelfsema F, Lamb HJ. van Thiel SW, et al. Among authors: de roos a. Int J Cardiovasc Imaging. 2004 Feb;20(1):53-60. doi: 10.1023/b:caim.0000013156.15274.5f. Int J Cardiovasc Imaging. 2004. PMID: 15055821 Clinical Trial.
Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.
Roes SD, Kaandorp TA, Marsan NA, Westenberg JJ, Dibbets-Schneider P, Stokkel MP, Lamb HJ, van der Wall EE, de Roos A, Bax JJ. Roes SD, et al. Among authors: de roos a. Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):594-601. doi: 10.1007/s00259-008-1001-0. Epub 2008 Dec 3. Eur J Nucl Med Mol Imaging. 2009. PMID: 19050879
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.
van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de Roos A, Kamp O, Paulus WJ, Heine RJ, Lammertsma AA, Smit JW, Diamant M. van der Meer RW, et al. Among authors: de jong hw, de roos a. Circulation. 2009 Apr 21;119(15):2069-77. doi: 10.1161/CIRCULATIONAHA.108.803916. Epub 2009 Apr 6. Circulation. 2009. PMID: 19349323 Free article. Clinical Trial.
918 results